Venus Remedies secures regulatory approvals for three key oncology drugs in Ukraine
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Cipla completes transfer of Generics Business Undertaking
BHL will undertake the development and supply of these molecules
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
It is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation
Bromfenac Ophthalmic Solution 0.075% (RLD BromSite) had estimated annual sales of USD 15 million in the U.S.
Gabapentin is indicated for the management of Postherpetic Neuraligia
 
        Subscribe To Our Newsletter & Stay Updated